Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial (Q40445632)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial |
scientific article |
Statements
1 reference
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial (English)
1 reference
Andrew Blauvelt
Diamant Thaçi
Eric L Simpson
Howard Sofen
Gianluca Pirozzi
Vera Mastey
Lisa A Beck
Thomas Bieber
Weily Soong
Makoto Kawashima
Richard Wu
Steven P Weinstein
Neil M H Graham
Ariel Teper
E Rand Sutherland
George D Yancopoulos
Marius Ardeleanu
7 October 2015
1 reference